Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREBOTPilot preoperative botulinum toxin before distal pancreatectomy
2019-002461-35Phase 2Terminated
- Sponsor
- Heidelberg University Faculty of Medicine
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of neuronox in pancreatic fistula (POPF) (2 arms), sponsored by Heidelberg University Faculty of Medicine. Primary endpoint: Clinically relevant postoperative pancreatic fistula and/or death within 30 days. Started Jul 2019; status: terminated.
02
Drugs
neuronox
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on 2019-002461-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002461-35.